NCT00577512View on ClinicalTrials.gov

2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Multiple Myeloma
Interventions
DRUG

DTPACE

"* Dexamethasone 200 mg Intravenous Infusion Piggy-Back (IVPB) Days 1-7~* Thalidomide 200 mg by mouth (PO) Days 1-7~* Cisplatin 15mg/m2 Days 1-4 (modify for renal insufficiency)~* Adriamycin 15 mg/m2 Days 1-4~* Cyclophosphamide 600 mg/m2 Days 1-4~* Etoposide 60 mg/m2 Days 1-4"

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT00577512 - 2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE | Biotech Hunter | Biotech Hunter